Sign inGet started

Lewis Michael E

Insider CIK 1297065 · AOLS Director · PYMX.OB Director · CARA Chief Scientific Advisor

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CARA Cara Therapeutics, Inc. A Award deriv2017-03-082017-03-1020,000— $020,000SEC↗
CARA Cara Therapeutics, Inc. A Award deriv2016-05-042016-06-1720,000— $020,000SEC↗
CARA Cara Therapeutics, Inc. S Sale2016-01-262016-01-277,262$10.93 $79.4K314,988SEC↗
CARA Cara Therapeutics, Inc. S Sale2015-07-012015-07-067,262$11.66 $84.7K322,250SEC↗
CARA Cara Therapeutics, Inc. S Sale2015-06-012015-06-027,262$9.50 $69.0K329,512SEC↗
CARA Cara Therapeutics, Inc. S Sale2015-05-012015-05-057,262$10.64 $77.3K336,774SEC↗
CARA Cara Therapeutics, Inc. S Sale2015-04-012015-04-027,262$9.90 $71.9K344,036SEC↗
CARA Cara Therapeutics, Inc. S Sale2015-03-022015-03-037,262$10.11 $73.4K351,298SEC↗
CARA Cara Therapeutics, Inc. S Sale2015-02-022015-02-037,262$10.60 $77.0K358,560SEC↗
CARA Cara Therapeutics, Inc. C Conversion deriv2014-02-052014-02-058,931— $00SEC↗
CARA Cara Therapeutics, Inc. C Conversion deriv2014-02-052014-02-05100,000— $00SEC↗
CARA Cara Therapeutics, Inc. C Conversion2014-02-052014-02-053,572— $0365,822SEC↗
CARA Cara Therapeutics, Inc. C Conversion2014-02-052014-02-0540,000— $0362,250SEC↗
CARA Cara Therapeutics, Inc. A Award deriv2014-01-302014-01-3140,000— $040,000SEC↗
AOLS AEOLUS PHARMACEUTICALS, IN A Award deriv2013-05-082013-05-1075,000— $075,000SEC↗
AOLS AEOLUS PHARMACEUTICALS, IN A Award deriv2012-10-092013-03-0611,250— $011,250SEC↗
AOLS AEOLUS PHARMACEUTICALS, IN A Award deriv2012-07-112013-03-0611,250— $011,250SEC↗
PYMX.OB POLYMEDIX, INC A Award deriv2012-03-262012-03-2837,000— $037,000SEC↗
AOLS AEOLUS PHARMACEUTICALS, IN A Award deriv2011-11-072013-03-0611,250— $011,250SEC↗
AOLS AEOLUS PHARMACEUTICALS, IN A Award deriv2011-04-132013-03-0611,250— $011,250SEC↗